{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:36:06Z","timestamp":1778942166027,"version":"3.51.4"},"reference-count":76,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ad.2016.11.010","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T12:04:14Z","timestamp":1483617854000},"page":"221-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Novedades terap\u00e9uticas en tricolog\u00eda"],"prefix":"10.1016","volume":"108","author":[{"given":"S.","family":"Va\u00f1\u00f3-Galv\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2016.11.010_bib0385","first-page":"185","article-title":"Topical minoxidil: Systematic review and meta-analysis of its efficacy in androgenetic alopecia","volume":"13","author":"Gupta","year":"2015","journal-title":"Skinmed."},{"key":"10.1016\/j.ad.2016.11.010_bib0390","first-page":"CD007628","article-title":"Interventions for female pattern hair loss","volume":"5","author":"Van Zuuren","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.ad.2016.11.010_bib0395","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/jdv.13324","article-title":"Effect of minoxidil topical foam on frontotemporal and vertex androgenetic alopecia in men: A 104-week open-label clinical trial","volume":"30","author":"Kanti","year":"2016","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2016.11.010_bib0400","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jaad.2010.09.724","article-title":"A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women","volume":"65","author":"Blume-Peytavi","year":"2011","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0405","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s13346-012-0083-1","article-title":"Niosomes as a vesicular carrier for topical administration of minoxidil: Formulation and in vitro assessment","volume":"3","author":"Mali","year":"2013","journal-title":"Drug Deliv Transl Res."},{"key":"10.1016\/j.ad.2016.11.010_bib0410","article-title":"Treatment of permanent chemotherapy-induced alopecia with low dose oral minoxidil","author":"Yang","year":"2015","journal-title":"Australas J Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0415","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jdcr.2016.02.011","article-title":"Treatment of monilethrix with oral minoxidil","volume":"2","author":"Sinclair","year":"2016","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.ad.2016.11.010_bib0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsxm.2016.07.006","article-title":"Effect of 5\u03b1-reductase inhibitors on sexual function: A meta-analysis and systematic review of randomized controlled trials","author":"Liu","year":"2016","journal-title":"J Sex Med."},{"key":"10.1016\/j.ad.2016.11.010_bib0425","first-page":"414","article-title":"Side effects related to 5 \u03b1-reductase inhibitor treatment of hair loss in women: A review","volume":"15","author":"Seale","year":"2016","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0430","doi-asserted-by":"crossref","first-page":"e0126672","DOI":"10.1371\/journal.pone.0126672","article-title":"Finasteride concentrations and prostate cancer risk: Results from the Prostate Cancer Prevention Trial","volume":"10","author":"Chau","year":"2015","journal-title":"PLoS One."},{"key":"10.1016\/j.ad.2016.11.010_bib0435","first-page":"1577","article-title":"Long-term use of 5\u03b1-reductase inhibitors and the risk of male breast cancer","volume":"25","author":"Duijnhoven","year":"2014","journal-title":"Cancer Causes Control."},{"key":"10.1016\/j.ad.2016.11.010_bib0440","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3109\/09546634.2013.813011","article-title":"The efficacy and safety of 5\u03b1-reductase inhibitors in androgenetic alopecia: A network meta-analysis and benefit-risk assessment of finasteride and dutasteride","volume":"25","author":"Gupta","year":"2014","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.ad.2016.11.010_bib0445","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4103\/0378-6323.144162","article-title":"The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia","volume":"80","author":"Boersma","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"10.1016\/j.ad.2016.11.010_bib0450","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4103\/0378-6323.188652","article-title":"Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study","volume":"83","author":"Shanshanwal","year":"2017","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"10.1016\/j.ad.2016.11.010_bib0455","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/ijd.12060","article-title":"Effect of dutasteride 0.5 mg\/d in men with androgenetic alopecia recalcitrant to finasteride","volume":"53","author":"Jung","year":"2014","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0460","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jaad.2013.10.049","article-title":"A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia","volume":"70","author":"Gubelin Harcha","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0465","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/1346-8138.13310","article-title":"Long-term safety and efficacy of dutasteride in the treatment of male patients with androgenetic alopecia","volume":"43","author":"Tsunemi","year":"2016","journal-title":"J Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0470","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1468-3083.2012.04535.x","article-title":"Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: Photographic, morphometric and ultrustructural evaluation","volume":"27","author":"Moftah","year":"2013","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2016.11.010_bib0475","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5414\/CP202467","article-title":"Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia","volume":"54","author":"Caserini","year":"2016","journal-title":"Int J Clin Pharmacol Ther."},{"key":"10.1016\/j.ad.2016.11.010_bib0480","doi-asserted-by":"crossref","first-page":"842","DOI":"10.5414\/CP202119","article-title":"A novel finasteride 0.25% topical solution for androgenetic alopecia: Pharmacokinetics and effects on plasma androgen levels in healthy male volunteers","volume":"52","author":"Caserini","year":"2014","journal-title":"Int J Clin Pharmacol Ther."},{"key":"10.1016\/j.ad.2016.11.010_bib0485","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jaad.2014.10.012","article-title":"Promising alternative clinical uses of prostaglandin F2\u03b1 analogs: Beyond the eyelashes","volume":"72","author":"Choi","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0490","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jaad.2011.05.026","article-title":"A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia","volume":"66","author":"Blume-Peytavi","year":"2012","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0495","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/exd.12348","article-title":"Does prostaglandin D2 hold the cure to male pattern baldness?","volume":"23","author":"Nieves","year":"2014","journal-title":"Exp Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0500","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1517\/13543784.2013.784743","article-title":"New investigational drugs for androgenetic alopecia","volume":"22","author":"Valente Duarte de Sousa","year":"2013","journal-title":"Expert Opin Investig Drugs."},{"key":"10.1016\/j.ad.2016.11.010_bib0505","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003122","article-title":"Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia","volume":"4","author":"Garza","year":"2012","journal-title":"Sci Transl Med."},{"key":"10.1016\/j.ad.2016.11.010_bib0510","first-page":"1036","article-title":"Emerging therapies for androgenetic alopecia","volume":"14","author":"Keaney","year":"2015","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0515","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10103-015-1818-2","article-title":"Low level laser therapy and hair regrowth: An evidence-based review","volume":"31","author":"Zarei","year":"2016","journal-title":"Lasers Med Sci."},{"key":"10.1016\/j.ad.2016.11.010_bib0520","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40257-013-0060-6","article-title":"Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: A multicenter, randomized, sham device-controlled, double-blind study","volume":"15","author":"Jimenez","year":"2014","journal-title":"Am J Clin Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0525","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/lsm.22170","article-title":"Low-level laser (light) therapy (LLLT) for treatment of hair loss","volume":"46","author":"Avci","year":"2014","journal-title":"Lasers Surg Med."},{"key":"10.1016\/j.ad.2016.11.010_bib0530","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/dsu.12200","article-title":"Low-level light therapy for androgenetic alopecia: A 24-week, randomized, double-blind, sham device-controlled multicenter trial","volume":"39","author":"Kim","year":"2013","journal-title":"Dermatol Surg."},{"key":"10.1016\/j.ad.2016.11.010_bib0535","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4103\/0974-7753.114700","article-title":"A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: A pilot study","volume":"5","author":"Dhurat","year":"2013","journal-title":"Int J Trichology."},{"key":"10.1016\/j.ad.2016.11.010_bib0540","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4103\/0019-5154.156361","article-title":"Response to microneedling treatment in men with androgenetic alopecia who failed to respond to conventional therapy","volume":"60","author":"Dhurat","year":"2015","journal-title":"Indian J Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0545","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.5966\/sctm.2015-0107","article-title":"The effect of platelet-rich plasma in hair regrowth: A randomized placebo-controlled trial","volume":"4","author":"Gentile","year":"2015","journal-title":"Stem Cells Transl Med."},{"key":"10.1016\/j.ad.2016.11.010_bib0550","first-page":"1","article-title":"Meta-analysis of efficacy of platelet-rich plasma therapy for androgenetic alopecia","author":"Gupta","year":"2016","journal-title":"J Dermatolog Treat."},{"key":"10.1016\/j.ad.2016.11.010_bib0555","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/DSS.0000000000000665","article-title":"Randomized placebo-controlled, double-blind half-head study to assess the efficacy of platelet-rich plasma on the treatment of androgenetic alopecia","volume":"42","author":"Alves","year":"2016","journal-title":"Dermatol Surg."},{"key":"10.1016\/j.ad.2016.11.010_bib0560","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.12225","article-title":"Topical application of the Wnt\/\u03b2-catenin activator methyl vanillate increases hair count and hair mass index in women with androgenetic alopecia","author":"Tosti","year":"2016","journal-title":"J Cosmet Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0565","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/1346-8138.12422","article-title":"Topical valproic acid increases the hair count in male patients with androgenetic alopecia: A randomized, comparative, clinical feasibility study using phototrichogram analysis","volume":"41","author":"Jo","year":"2014","journal-title":"J Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0570","doi-asserted-by":"crossref","first-page":"AB138","DOI":"10.1016\/j.jaad.2016.02.544","article-title":"Safety and efficacy of a topical treatment (SM04554) for androgenetic alopecia (AGA): Results from a phase 1 Trial","volume":"74","author":"Yazici","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0575","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/jmcb\/mjv005","article-title":"mTOR signaling promotes stem cell activation via counterbalancing BMP-mediated suppression during hair regeneration","volume":"7","author":"Deng","year":"2015","journal-title":"J Mol Cell Biol."},{"key":"10.1016\/j.ad.2016.11.010_bib0580","doi-asserted-by":"crossref","first-page":"e1500973","DOI":"10.1126\/sciadv.1500973","article-title":"Pharmacologic inhibition of JAK-STAT signaling promotes hair growth","volume":"1","author":"Harel","year":"2015","journal-title":"Sci Adv."},{"key":"10.1016\/j.ad.2016.11.010_bib0585","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1038\/jid.2015.248","article-title":"Photoactivation of ROS production in situ transiently activates cell proliferation in mouse skin and in the hair follicle stem cell niche promoting hair growth and wound healing","volume":"135","author":"Carrasco","year":"2015","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0590","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1523-1747.2003.12568.x","article-title":"Cultured peribulbar dermal sheath cells can induce hair follicle development and contribute to the dermal sheath and dermal papilla","volume":"121","author":"McElwee","year":"2003","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0595","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/ijd.12650","article-title":"Clinical use of conditioned media of adipose tissue-derived stem cells in female pattern hair loss: A retrospective case series study","volume":"54","author":"Shin","year":"2015","journal-title":"Int J Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0600","first-page":"e10","article-title":"Hair regeneration treatment using adipose-derived stem cell conditioned medium: Follow-up with trichograms","volume":"15","author":"Fukuoka","year":"2015","journal-title":"Eplasty."},{"key":"10.1016\/j.ad.2016.11.010_bib0605","doi-asserted-by":"crossref","DOI":"10.1177\/2041731414556850","article-title":"A review of adipocyte lineage cells and dermal papilla cells in hair follicle regeneration","volume":"5","author":"Zhang","year":"2014","journal-title":"J Tissue Eng."},{"key":"10.1016\/j.ad.2016.11.010_bib0610","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/ced.12776","article-title":"Retrospective review of diphencyprone in the treatment of alopecia areata","volume":"41","author":"Lamb","year":"2016","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0615","doi-asserted-by":"crossref","first-page":"372e1","DOI":"10.1016\/j.jaad.2015.09.045","article-title":"A systematic review of pulse steroid therapy for alopecia areata","volume":"74","author":"Shreberk-Hassidim","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0620","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jaad.2015.12.026","article-title":"Pulse corticosteroid therapy with oral dexamethasone for the treatment of adult alopecia totalis and universalis","volume":"74","author":"Va\u00f1o Galv\u00e1n","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0625","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jaad.2014.11.006","article-title":"Treatment of alopecia areata with simvastatin\/ezetimibe","volume":"72","author":"Lattouf","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0630","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.jaad.2015.09.071","article-title":"Alopecia areata (AA) and treatment with simvastatin\/ezetimibe: Experience of 20 patients","volume":"74","author":"Loi","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0635","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat Med."},{"key":"10.1016\/j.ad.2016.11.010_bib0640","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jamadermatol.2015.4445","article-title":"Topical ruxolitinib for the treatment of alopecia universalis","volume":"152","author":"Craiglow","year":"2016","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0645","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ebiom.2015.02.015","article-title":"Reversal of alopecia areata following treatment with the JAK1\/2 inhibitor baricitinib","volume":"2","author":"Jabbari","year":"2015","journal-title":"EBioMedicine."},{"key":"10.1016\/j.ad.2016.11.010_bib0650","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jaad.2015.09.073","article-title":"Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)","volume":"74","author":"Harris","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0655","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/exd.13060","article-title":"Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers","volume":"25","author":"Jabbari","year":"2016","journal-title":"Exp Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0660","article-title":"Successful treatment of refractory alopecia areata universalis and psoriatic arthritis, but not of plaque psoriasis with tofacitinib in a young woman","author":"Mrowietz","year":"2016","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2016.11.010_bib0665","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/jdv.13598","article-title":"Efficacy of tofacitinib in treatment of alopecia universalis in two patients","volume":"30","author":"Gupta","year":"2016","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2016.11.010_bib0670","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000445182","article-title":"Transient efficacy of tofacitinib in alopecia areata universalis","volume":"8","author":"Anzengruber","year":"2016","journal-title":"Case Rep Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0675","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2013.12.003","article-title":"Frontal fibrosing alopecia: A multicenter review of 355 patients","volume":"70","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0680","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2012.09.043","article-title":"Frontal fibrosing alopecia: A retrospective review of 19 patients seen at Duke University","volume":"68","author":"Ladizinski","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0685","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.jaad.2015.11.047","article-title":"Antiandrogenic drugs, a therapeutic option for frontal fibrosing alopecia patients","volume":"74","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0690","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/jdv.12362","article-title":"Treatment of frontal fibrosing alopecia and lichen planopilaris","volume":"28","author":"Harries","year":"2014","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2016.11.010_bib0695","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ad.2014.12.002","article-title":"Frontal fibrosing alopecia: An update on epidemiology and treatment","volume":"106","author":"Mart\u00ednez-P\u00e9rez","year":"2015","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2016.11.010_bib0700","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jdcr.2015.08.003","article-title":"Finasteride-mediated hair regrowth and reversal of atrophy in a patient with frontal fibrosing alopecia","volume":"1","author":"Donovan","year":"2015","journal-title":"JAAD Case Rep."},{"key":"10.1016\/j.ad.2016.11.010_bib0705","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.jaad.2015.09.076","article-title":"Finasteride is of uncertain utility in treating frontal fibrosing alopecia","volume":"74","author":"Tziotzios","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0710","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/jid.2008.369","article-title":"Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia","volume":"129","author":"Karnik","year":"2009","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0715","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jaad.2013.04.066","article-title":"Lichen planopilaris treated by the peroxisome proliferator activated receptor-\u03b3 agonist pioglitazone: Lack of lasting improvement or cure in the majority of patients","volume":"69","author":"Spring","year":"2013","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0720","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaad.2014.10.036","article-title":"The use of oral pioglitazone in the treatment of lichen planopilaris","volume":"72","author":"Mesinkovska","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0725","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/archdermatol.2009.283","article-title":"Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist","volume":"145","author":"Mirmirani","year":"2009","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0730","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2310\/7750.2011.11008","article-title":"Use of pioglitazone in patients with lichen planopilaris","volume":"16","author":"Baibergenova","year":"2012","journal-title":"J Cutan Med Surg."},{"key":"10.1016\/j.ad.2016.11.010_bib0735","first-page":"66","article-title":"Tratamiento de la alopecia frontal fibrosante: pioglitazonas","volume":"29","author":"M\u00e1rquez-Garc\u00eda","year":"2016","journal-title":"Monogr Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0740","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/jdv.12993","article-title":"Folliculitis decalvans: A multicentre review of 82 patients","volume":"29","author":"Va\u00f1\u00f3-Galv\u00e1n","year":"2015","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2016.11.010_bib0745","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jaad.2015.02.1120","article-title":"Treatment of folliculitis decalvans with photodynamic therapy: Results in 10 patients","volume":"72","author":"Miguel-Gomez","year":"2015","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0750","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.jaad.2015.09.075","article-title":"Failure of photodynamic therapy (PDT) in 3 patients with folliculitis decalvans","volume":"74","author":"Burillo-Martinez","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2016.11.010_bib0755","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/DSS.0000000000000191","article-title":"Robotic follicular unit extraction in hair transplantation","volume":"40","author":"Avram","year":"2014","journal-title":"Dermatol Surg."},{"key":"10.1016\/j.ad.2016.11.010_bib0760","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000369416","article-title":"Advances in hair transplantation: Longitudinal partial follicular unit transplantation","volume":"47","author":"Gho","year":"2015","journal-title":"Curr Probl Dermatol."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731016304379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731016304379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:05:47Z","timestamp":1757552747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731016304379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0001731016304379"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2016.11.010","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novedades terap\u00e9uticas en tricolog\u00eda","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2016.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}